Monique da Silva

No open positions remaining

Health Technology

Commercial Services

Consumer Services

Profile

Monique da Silva worked at Ogilvy Public Relations Worldwide, Inc. as EVP & Head-North America Healthcare Practice.
Worked at Spark Therapeutics, Inc. as Vice President-Corporate Communications from 2016 to 2020.
Worked at AVROBIO, Inc. as Senior Vice President-Corporate Communications.
Worked at AnaptysBio, Inc. as Senior Vice President-Corporate Affairs.
Completed undergraduate education at Bowdoin College.

Former positions of Monique da Silva

Companies	Position	End
ANAPTYSBIO, INC.	Corporate Officer/Principal	31/03/2026
SPARK THERAPEUTICS, INC.	Public Communications Contact	31/12/2019
TECTONIC THERAPEUTIC, INC.	Public Communications Contact	-
Ogilvy Public Relations Worldwide, Inc. Ogilvy Public Relations Worldwide, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations and marketing solutions	Corporate Officer/Principal	-

See the detail of Monique da Silva's experience

Training of Monique da Silva

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Monique da Silva's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
AnaptysBio, Inc. AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company	Health Technology
Ogilvy Public Relations Worldwide, Inc. Ogilvy Public Relations Worldwide, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations and marketing solutions	Commercial Services
Bowdoin College Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Spark Therapeutics, Inc. Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases	Health Technology
AVROBIO, Inc. AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose	Health Technology